Metabolic syndrome and mitochondrial dysfunction: insights from preclinical studies with a mitochondrially targeted antioxidant

Free Radic Biol Med. 2012 Mar 1;52(5):838-40. doi: 10.1016/j.freeradbiomed.2011.12.014. Epub 2011 Dec 22.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Kommentar

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Apolipoproteins E / genetics*
  • Ataxia Telangiectasia Mutated Proteins
  • Atherosclerosis / drug therapy*
  • Cell Cycle Proteins / genetics*
  • DNA-Binding Proteins / genetics*
  • Female
  • Male
  • Metabolic Syndrome / drug therapy*
  • Mitochondria / drug effects*
  • Organophosphorus Compounds / pharmacology*
  • Protein Serine-Threonine Kinases / genetics*
  • Tumor Suppressor Proteins / genetics*
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / pharmacology

Substances

  • Antioxidants
  • Apolipoproteins E
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Organophosphorus Compounds
  • Tumor Suppressor Proteins
  • Ubiquinone
  • mitoquinone
  • Ataxia Telangiectasia Mutated Proteins
  • Protein Serine-Threonine Kinases